298 related articles for article (PubMed ID: 22404857)
1. Under-grading of <4 cm renal masses on renal biopsy.
Harris CR; Whitson JM; Meng MV
BJU Int; 2012 Sep; 110(6):794-7. PubMed ID: 22404857
[TBL] [Abstract][Full Text] [Related]
2. Evolving practice patterns for the management of small renal masses in the USA.
Yang G; Villalta JD; Meng MV; Whitson JM
BJU Int; 2012 Oct; 110(8):1156-61. PubMed ID: 22372984
[TBL] [Abstract][Full Text] [Related]
3. Tumour size, tumour complexity, and surgical approach are associated with nephrectomy type in small renal cortical tumours treated electively.
Broughton GJ; Clark PE; Barocas DA; Cookson MS; Smith JA; Herrell SD; Chang SS
BJU Int; 2012 Jun; 109(11):1607-13. PubMed ID: 21939493
[TBL] [Abstract][Full Text] [Related]
4. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
[TBL] [Abstract][Full Text] [Related]
5. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
[TBL] [Abstract][Full Text] [Related]
6. Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases.
Abel EJ; Carrasco A; Culp SH; Matin SF; Tamboli P; Tannir NM; Wood CG
BJU Int; 2012 Dec; 110(11):1742-6. PubMed ID: 22503066
[TBL] [Abstract][Full Text] [Related]
7. How often are patients with diabetes or hypertension being treated with partial nephrectomy for renal cell carcinoma? A population-based analysis.
Abouassaly R; Finelli A; Tomlinson GA; Urbach DR; Alibhai SM
BJU Int; 2011 Dec; 108(11):1806-12. PubMed ID: 21599823
[TBL] [Abstract][Full Text] [Related]
8. The correlation between size of renal cell carcinoma and its histopathological characteristics: a single center study of 1867 renal cell carcinoma cases.
Zhang C; Li X; Hao H; Yu W; He Z; Zhou L
BJU Int; 2012 Dec; 110(11 Pt B):E481-5. PubMed ID: 22540142
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
[TBL] [Abstract][Full Text] [Related]
10. Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis.
Choueiri TK; Schutz FA; Hevelone ND; Nguyen PL; Lipsitz SR; Williams SB; Silverman SG; Hu JC
Urology; 2011 Jul; 78(1):93-8. PubMed ID: 21550636
[TBL] [Abstract][Full Text] [Related]
11. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
12. Treatment management of small renal masses in the 21st century: a paradigm shift.
Sun M; Abdollah F; Bianchi M; Trinh QD; Jeldres C; Thuret R; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
Ann Surg Oncol; 2012 Jul; 19(7):2380-7. PubMed ID: 22322956
[TBL] [Abstract][Full Text] [Related]
13. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.
Stern JM; Svatek R; Park S; Hermann M; Lotan Y; Sagalowsky AI; Cadeddu JA
BJU Int; 2007 Aug; 100(2):287-90. PubMed ID: 17617136
[TBL] [Abstract][Full Text] [Related]
14. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
[TBL] [Abstract][Full Text] [Related]
15. Predictors of locally advanced and metastatic disease in patients with small renal masses.
Kates M; Korets R; Sadeghi N; Pierorazio PM; McKiernan JM
BJU Int; 2012 May; 109(10):1463-7. PubMed ID: 21933329
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
17. A non-cancer-related survival benefit is associated with partial nephrectomy.
Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
[TBL] [Abstract][Full Text] [Related]
18. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
[TBL] [Abstract][Full Text] [Related]
19. Incomplete thermal ablation stimulates proliferation of residual renal carcinoma cells in a translational murine model.
Kroeze SG; van Melick HH; Nijkamp MW; Kruse FK; Kruijssen LW; van Diest PJ; Bosch JL; Jans JJ
BJU Int; 2012 Sep; 110(6 Pt B):E281-6. PubMed ID: 22612555
[TBL] [Abstract][Full Text] [Related]
20. Population-based comparative effectiveness of nephron-sparing surgery vs ablation for small renal masses.
Whitson JM; Harris CR; Meng MV
BJU Int; 2012 Nov; 110(10):1438-43; discussion 1443. PubMed ID: 22639860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
